Cargando…

Insights into Urologic Cancer

Detalles Bibliográficos
Autores principales:	Klümper, Niklas, Ellinger, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295856/ https://www.ncbi.nlm.nih.gov/pubmed/37370718 http://dx.doi.org/10.3390/cancers15123108

Ejemplares similares

Insights into Urological Cancer
por: Manini, Claudia, et al.
Publicado: (2021)

Epigenetics of Urological Cancers
por: Schulz, Wolfgang A., et al.
Publicado: (2019)

Pathology of Urologic Cancers
por: Tossetta, Giovanni, et al.
Publicado: (2022)

Early C-reactive protein kinetics predicts immunotherapy response in non-small cell lung cancer in the phase III OAK trial
por: Saal, Jonas, et al.
Publicado: (2023)

Downstream neighbor of SON (DONSON) is associated with unfavorable survival across diverse cancers with oncogenic properties in clear cell renal cell carcinoma
por: Klümper, Niklas, et al.
Publicado: (2020)

Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors
por: Saal, Jonas, et al.
Publicado: (2023)

Next generation sequencing and urologic cancer
por: Kim, Seon-Kyu, et al.
Publicado: (2015)

Biology and therapy of urological cancer metastasis
por: Posadas, Edwin M., et al.
Publicado: (2016)

Mediator Complex Subunit MED1 Protein Expression Is Decreased during Bladder Cancer Progression
por: Klümper, Niklas, et al.
Publicado: (2017)

Laparoscopy in urology
por: Hemal, Ashok K., et al.
Publicado: (2005)

The Microbiome and Urology
por: Cho, Young Sam
Publicado: (2021)

Surveys in urology
por: Kumar, Rajeev
Publicado: (2022)

Urology in Pediatrics
por: Cobellis, Giovanni
Publicado: (2022)

CircEHD2, CircNETO2 and CircEGLN3 as Diagnostic and Prognostic Biomarkers for Patients with Renal Cell Carcinoma
por: Frey, Lisa, et al.
Publicado: (2021)

True open access to urological science at the International Brazilian Journal of Urology
Publicado: (2023)

Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer
por: Condic, Mateja, et al.
Publicado: (2022)

Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer
por: Ralser, Damian J., et al.
Publicado: (2022)

Urology in the next century
por: Kekre, Nitin S.
Publicado: (2007)

Advances in Prosthetic Urology
por: Henry, Gerard D., et al.
Publicado: (2012)

Pediatric urology in the KJU
por: Kang, Jung Yoon
Publicado: (2015)

Regenerative pharmacology in urology
por: Andersson, Karl-Erik, et al.
Publicado: (2017)

American Journal of Urology
Publicado: (1905)

The American Journal of Urology
Publicado: (1904)

Journal title changes from Korean Journal of Urology to Investigative and Clinical Urology
por: Park, Kwangsung
Publicado: (2016)

The Importance of Reporting Clinical and Epidemiological Data in Urology: Local Experiences and Insights from the International Literature
por: Gajdács, Márió
Publicado: (2020)

Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2–ERG-Positive Primary Prostate Cancers
por: von Danwitz, Marthe, et al.
Publicado: (2023)

Surgery for urological cancers
por: Sengupta, Shomik
Publicado: (2020)

LESS in urology
por: Rao, Pradeep P, et al.
Publicado: (2012)

Urological myriad
Publicado: (2018)

Military Urology
Publicado: (1918)

Training of a urology resident
por: Kekre, Nitin S.
Publicado: (2009)

Lab-on-a-chip for Urology
por: Kim, Khae Hawn
Publicado: (2013)

New horizons in geriatric urology
por: Kim, Hyung Jee
Publicado: (2015)

Editorial: Urology Mini Symposium
por: Kabala, Julian
Publicado: (1992)

Urology in India: Numbers and practice
por: Goel, Apul
Publicado: (2019)

Gender Equality in Indian Urology
por: Sinha, Sanjay, et al.
Publicado: (2022)

The paradox of why and how in urology!
por: Mandhani, Anil
Publicado: (2022)

Downstream Neighbor of SON (DONSON) Expression Is Enhanced in Phenotypically Aggressive Prostate Cancers
por: Klümper, Niklas, et al.
Publicado: (2020)

Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma
por: Schrödter, Sarah, et al.
Publicado: (2016)

Personalized Cancer Therapy for Urological Cancers: From Bench to Bedside and Back
por: Uemura, Hirotsugu, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_i4pr6sa5t40vd9jm9n7p7sfqgh